US FDA approves first drug under new fast-track review program – Reuters

1. US FDA approves first drug under new fast-track review program  Reuters
2. Whither the FDA’s Commissioner’s National Priority Voucher?  The American Action Forum
3. FDA Grants First Approval Under Priority Voucher Program, Fast-Tracking Antibiotic to Strengthen US Drug Supply Chain  Contagion Live
4. What MFN Pricing Means for Future Drug Development  Pharmaceutical Commerce
5. CNPV Limits May Not Slow Collaboration or Commercialization  Pharmaceutical Commerce

Continue Reading